OKLAHOMA CITY, OK
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)OKLAHOMA SOCIETY OF CLINICAL ONCOLOGY I, founded in 1985, is a small nonprofit that reported $197K in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $181K left a modest 8% surplus.
ADVANCE THE SCIENCES OF HEMATOLOGY AND ONCOLOGY AND ITS SUBSPECIALTIES AND IMPROVE SERVICES TO THE PUBLIC BY STUDYING THE SOCIOECONOMIC ASPECTS OF THE PRACTICES OF ITS MEMBERS.
ON NOVEMBER 16, 2024, OSCO HELD AN IN-PERSON CONFERENCE, ENTITLED BEST OF ASCO. THIS LICENSED SEMINAR FOCUSED ON THE FOREMOST RESEARCH AND STRATEGIES IN ONCOLOGY THAT WERE PRESENTED AT THE 2024...
ON NOVEMBER 16, 2024, OSCO HELD AN IN-PERSON CONFERENCE, ENTITLED BEST OF ASCO. THIS LICENSED SEMINAR FOCUSED ON THE FOREMOST RESEARCH AND STRATEGIES IN ONCOLOGY THAT WERE PRESENTED AT THE 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING. ON APRIL 12, 2025, OSCO HELD AN IN-PERSON CONFERENCE WITH TOPICS FROM THE "BEST OF SAN ANTONIO BREAST CANCER SYMPOSIUM," WHICH WAS HELD IN DECEMBER 2024. THE SEMINAR PROVIDED THE LATEST STATE-OF-THE-ART INFORMATION ON THE EXPERIMENTAL BIOLOGY, ETIOLOGY, PREVENTION, DIAGNOSIS, AND THERAPY OF BREAST CANCER AND PREMALIGNANT BREAST DISEASE. THE SEMINAR WAS DIRECTED TOWARDS HEALTH CARE PROFESSIONALS INVOLVED IN BREAST CANCER IN MEDICAL, SURGICAL, GYNECOLOGIC, AND RADIATION ONCOLOGY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $196,776 | $177,762 | +0.1% |
| Expenses | $181,275 | $187,466 | 0.0% |
| Net Income | $15,501 | $-9,704 | -2.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CHRISTINA E HENSON MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JORDAN M MORTON MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| RAID ALJUMAILY MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSANNA ULAHANNAN MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ADANMA AYANAMBAKKAM MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| PAUL EL TOMB MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT COLE MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSE EUGENIO NAJERA MD | PRESIDENT | 1.00 |
Officer
|
$0 | $0 | $0 |
| WILLIAM C DOOLEY MD | TREASURER | 1.00 |
Officer
|
$0 | $0 | $0 |
| KATHLEEN A MUSSON CAE | EXECUTIVE DIRECTOR | 20.00 |
Officer
|
$18,667 | $0 | $18,667 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $196,776 | $181,275 | $592,893 | $15,501 |
| 2024 | $177,762 | $187,466 | $557,971 | $-9,704 |
| 2023 | $178,124 | $143,444 | $554,719 | $34,680 |
| 2022 | $209,783 | $136,065 | $491,209 | $73,718 |
| 2021 | $204,617 | $84,251 | $492,590 | $120,366 |
| 2020 | $154,570 | $115,985 | $335,138 | $38,585 |
| 2019 | $162,201 | $120,870 | $302,063 | $41,331 |
| 2018 | $223,380 | $146,484 | $260,678 | $76,896 |
Compare OKLAHOMA SOCIETY OF CLINICAL ONCOLOGY I with other nonprofits in Oklahoma and across the country.